| Understanding Women's Contraceptive Expectations at the Time of a First Trimester Surgical Abortion (NCT01807715) | University of California, Davis | 2012-12-01 |
| Smoking, Sex Hormones, and Pregnancy (NCT01811225) | University of Minnesota | 2012-12-01 |
| A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test (NCT01740687) | Bayer | 2012-11-13 |
| Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448) (NCT01656434) | Organon and Co | 2012-11-02 |
| Randomized Controlled Trial of Adjunctive Social Media for More Effective Contraceptive Counseling (NCT01994005) | New York Presbyterian Hospital | 2012-10-01 |
| Plan A Birth Control: Randomized Controlled Trial of a Mobile Health Application for Contraception Information (NCT02234271) | University of California, Los Angeles | 2012-09-01 |
| Mobile Phone Text Messaging Referral (NCT01746758) | Liverpool School of Tropical Medicine | 2012-08-01 |
| Bedsider.Org in Post-abortion Contraceptive Counseling: A Mixed Methods Study (NCT02532946) | Boston Medical Center | 2012-08-01 |
| Postpartum Etonogestrel Implant for Adolescents (NCT01666912) | University of North Carolina, Chapel Hill | 2012-08-01 |
| ESS505 Pre-hysterectomy Protocol (NCT01664052) | Bayer | 2012-07-01 |
| Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg) (NCT01650168) | Center for Epidemiology and Health Research, Germany | 2012-07-01 |
| DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users. (NCT01731132) | Bayer | 2012-07-01 |
| Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice Females (NCT02252471) | University of Houston | 2012-07-01 |
| Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects (NCT01638910) | Bayer | 2012-06-01 |
| EMR Referrals for Teratogen and Contraceptive Counseling for Category D or X Medication Users: RCT (NCT02293213) | University of California, San Diego | 2012-04-01 |
| A Study to Evaluate the Safety and Initial Efficacy of a Novel Intrauterine Device (NCT01590563) | Ocon Medical Ltd. | 2012-04-01 |
| The Effect of Nitroglycerin on the Intrauterine Device (IUD) Insertion Experience in Nulliparous Women (NCT01490073) | Oregon Health and Science University | 2012-03-01 |
| Early Postpartum Intrauterine Device (IUD) Placement (NCT01594476) | Oregon Health and Science University | 2012-03-01 |
| eKISS: Electronic KIOSK Intervention for Safer-Sex (NCT03027531) | University of Washington | 2012-02-01 |
| The Influence of Trust in the Health Care System on Postpartum Contraceptive Choice (NCT02213874) | Medical University of South Carolina | 2012-01-01 |
| Egyptian Women Knowledge and Use of Different Contraceptive Methods (NCT01520090) | Ain Shams University | 2012-01-01 |
| Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733) (NCT01490190) | Organon and Co | 2011-12-26 |
| Long-Acting Reversible Contraception (NCT01299116) | FHI 360 | 2011-12-01 |
| Effectiveness of Prolonged Use of IUD/Implant for Contraception (NCT02267616) | Indiana University | 2011-12-01 |
| Nexplanon Observational Risk Assessment Study (NORA) (NCT01473641) | Center for Epidemiology and Health Research, Germany | 2011-11-01 |
| Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression (NCT01463202) | Beatrice Chen | 2011-11-01 |
| Evaluation of a Contraceptive Counseling Intervention in Deprived Neighborhoods: SIRIAN Randomized Controlled Trial (NCT02819388) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2011-10-01 |
| A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan (NCT01463254) | FHI 360 | 2011-10-01 |
| A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450) (NCT01277211) | Organon and Co | 2011-09-19 |
| Enhancing Uptake of Family Planning Services by HIV-Infected Women Attending the PMTCT Program (NCT03019601) | Johns Hopkins University | 2011-09-01 |
| Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction (NCT01590537) | Bayer | 2011-09-01 |
| LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study (NCT01397097) | Bayer | 2011-09-01 |
| Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users (NCT02362373) | Columbia University | 2011-08-01 |
| Intra Uterine Device Insertion in Nulliparous Women (NCT01422226) | University of Colorado, Denver | 2011-07-01 |
| Study of Birth Control Use After Childbirth (NCT01443533) | WakeMed Health and Hospitals | 2011-05-01 |
| Ulipristal Emergency Contraception Used Before or After Ovulation (NCT02517463) | The University of Hong Kong | 2011-05-01 |
| Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel (NCT01306331) | Evofem Inc. | 2011-04-01 |
| RCT: Can a Single Counseling Phone Call Improve Contraception After an Abortion? (NCT01199952) | University of California, San Francisco | 2011-03-21 |
| Immediate Post-placental Insertion of the Copper T 380A After Cesarean Delivery Versus 6 Week Post-cesarean Insertion (NCT01293760) | Planned Parenthood League of Massachusetts | 2011-02-01 |
| LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study (NCT01254292) | Bayer | 2011-01-06 |
| Physician Self Disclosure of IUC Use (NCT01994356) | University of Michigan | 2011-01-01 |
| A Multicenter, Open-Label, Non-Comparative Study of the Safety and Contraceptive Efficacy of the Woman's Condom (NCT01223313) | Premier Research | 2011-01-01 |
| Computer-Assisted Provision of Reproductive Health Care (NCT00829517) | University of Pittsburgh | 2011-01-01 |
| Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement (NCT01496898) | University of Utah | 2011-01-01 |
| A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG) (NCT01166412) | Premier Research | 2010-12-01 |
| Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function (NCT01257984) | Bayer | 2010-12-01 |
| INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study) (NCT01266408) | Center for Epidemiology and Health Research, Germany | 2010-11-22 |
| Postpartum Intrauterine Device Study (NCT01175161) | University of North Carolina, Chapel Hill | 2010-10-01 |
| Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557) (NCT01181778) | Organon and Co | 2010-10-01 |
| Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm (NCT01236768) | Agile Therapeutics | 2010-10-01 |
| Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion. (NCT01223521) | Helsinki University Central Hospital | 2010-09-01 |
| IUD Insertion Post First Trimester Abortion (NCT01174225) | University of British Columbia | 2010-09-01 |
| Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2 (NCT01221831) | Estetra | 2010-09-01 |
| Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women. (NCT01204190) | Bayer | 2010-09-01 |
| A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy (NCT01178125) | Teva Branded Pharmaceutical Products R&D, Inc. | 2010-08-01 |
| Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices (NCT01192490) | University of Tennessee | 2010-08-01 |
| Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System (NCT01181479) | Agile Therapeutics | 2010-08-01 |
| A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum Period (NCT01161095) | United States Naval Medical Center, Portsmouth | 2010-07-01 |
| Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women (NCT01147497) | Emory University | 2010-06-01 |
| Pharmacokinetic and Pharmacodynamic Study of Cyclofem (NCT01699022) | Sun Pharmaceutical Industries Limited | 2010-06-01 |
| Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women (NCT01107106) | HRA Pharma | 2010-05-01 |
| PK of Depo SubQ Injected in the Upper Arm (NCT01143207) | FHI 360 | 2010-05-01 |
| Study of Self or Clinic Administration of DepoProvera (NCT01019369) | Carolyn L. Westhoff | 2010-03-01 |
| Postpartum Family Planning Service Through Enhanced Family Planning in Immunization Services (NCT01115361) | FHI 360 | 2010-02-01 |
| FR01 and FR20 IUS (Intrauterine System) Wearing Study (NCT01595022) | Bayer | 2010-01-01 |
| ChoicesPlus: Reducing Alcohol- and Tobacco-Exposed Pregnancy (NCT01032772) | University of Texas at Austin | 2010-01-01 |
| Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium (NCT01031355) | Bayer | 2009-12-01 |
| Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period (NCT01088178) | United States Naval Medical Center, Portsmouth | 2009-11-01 |
| An Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Etonogestrel-releasing Medicated Intrauterine Systems (Study P06060) (NCT00967746) | Organon and Co | 2009-11-01 |
| A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception (NCT00995150) | Medicines360 | 2009-11-01 |
| Use of Misoprostol for Intrauterine Device (IUD) Insertion in Nulliparous Women (NCT01001897) | University of Arizona | 2009-10-01 |
| Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites (NCT01083264) | Bayer | 2009-10-01 |
| International Active Surveillance Study - Safety of Contraceptives: Role of Estrogens (NCT01009684) | Center for Epidemiology and Health Research, Germany | 2009-08-01 |
| Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement (NCT01598662) | University of Louisville | 2009-07-01 |
| Transdermal Contraceptive Patch - Endometrial Effects Study (NCT00896571) | Bayer | 2009-07-01 |
| Regulatory Post Marketing Surveillance Study on YAZ (NCT00998257) | Bayer | 2009-07-01 |
| Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD) (NCT00915915) | Bayer | 2009-06-01 |
| FC Patch Low: Metabolism Study (NCT00933179) | Bayer | 2009-06-01 |
| US Cycle Control and Blood Pressure Study (NCT00920985) | Bayer | 2009-06-01 |
| Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC) (NCT00905684) | Bayer | 2009-06-01 |
| Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men (NCT00891228) | Premier Research | 2009-05-01 |
| Birth Control Patch Study (NCT00984789) | Bayer | 2009-05-01 |
| Mirena Observational Program (NCT00883662) | Bayer | 2009-05-01 |
| US Ovulation Inhibition Study in Obese Women (NCT00873483) | Bayer | 2009-04-30 |
| EU/LA Pearl Index Study - Transdermal Contraceptive Patch (NCT00914693) | Bayer | 2009-04-01 |
| GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China (NCT00884260) | Bayer | 2009-04-01 |
| Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (NCT01096498) | Bayer | 2009-02-01 |
| Contraceptive Awareness and Reproductive Education (NCT01132950) | Memorial Hospital of Rhode Island | 2009-02-01 |
| Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (NCT01096485) | Bayer | 2009-02-01 |
| Drug Utilization Study on the Prescribing Indications for Yasmin® and Other OCs in Croatia (NCT01319500) | Center for Epidemiology and Health Research, Germany | 2009-02-01 |
| A Randomized Controlled Trial of Three Vasectomy Techniques (NCT00612833) | FHI 360 | 2009-01-01 |
| Effects of SH T00658ID on Libido (NCT00764881) | Bayer | 2009-01-01 |
| YAZ, Oral Contraceptive Registration in China (NCT00819312) | Bayer | 2008-12-01 |
| Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia (NCT00807625) | University of Alabama at Birmingham | 2008-11-01 |
| A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC (NCT00789802) | Washington University School of Medicine | 2008-11-01 |
| ORAL T-6: Oral Androgens in Man-6 (NCT00663793) | University of Washington | 2008-10-01 |
| Randomized Controlled Trial of Structured Contraceptive Counseling in Adult Women (NCT00746993) | Columbia University | 2008-10-01 |
| Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives (NCT00775190) | Corewell Health East | 2008-10-01 |
| Electronic Notification of Teratogenic Risks (NCT00766207) | University of Pittsburgh | 2008-10-01 |
| To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada) (NCT00754065) | Bayer | 2008-09-08 |